• Bayer HealthCare Pharmaceuticals Inc., of Wayne, N.J., signed a three-year agreement with the California Institute for Quantitative Biosciences (QB3) to evaluate life sciences start-up companies with the goal of advancing early stage technologies and therapeutics. Mission Bay Capital LLC will provide seed funding to the selected companies.